Several groups have recently reported comparative analyses for male versus female breast cancers, but these studies failed to be adjusted for a variety of prognostic relevant parameters in breast cancer like age, tumor size, nodal stage, tumor grade hormone receptors and HER2 expression [10-16]. The gene discussed is ERBB2; the disease is breast carcinoma.